SecProbe.io

CORRESP
1
filename1.htm

MEDI
Group Ltd

Unit
15-16, 22/F., CEO Tower

77
Wing Hong Street

Cheung
Sha Wan

Kowloon,
Hong Kong

September
29, 2025

VIA
EDGAR

Division
of Corporation Finance

Office
of Trade & Services

U.S.
Securities and Exchange Commission (the “Commission”)

100
F Street, NE

Washington,
D.C. 20549

    Attention:
    Scott
                                            Anderegg

    Donald
    Field

    Adam
    Phippen

    Joel
    Parker

  Re:
  MEDI Group Ltd (the “Company”)

      Registration Statement on Form F-1,as amended (CIK No. 0002022097)

      (the “Registration Statement”)

      File No. 333-289774

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as
amended (the “Securities Act”), the Company hereby requests acceleration of effectiveness of the above referenced
Registration Statement so that it will become effectiveness at 5:30pm ET on September 30, 2025, or as soon as thereafter practicable.

The
Company understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Company is aware of its responsibilities under the Securities Act as they relate to the proposed
public offering of the securities specified in the Registration Statement.

    MEDI
    Group Ltd

    By:
    /s/
    NG Hong Kin

    Name:
    NG
    Hong Kin

    Title:
    Chief
    Executive Officer (Principal Executive Officer) and Executive Director